DNA guanine bases (G)

DNA guanine bases are one of the four fundamental nitrogenous bases that constitute the genetic code within the DNA double helix. In the field of oncology and pharmacology, guanine is a critical molecular target because its nucleophilic nitrogen (N7) and oxygen (O6) atoms are highly susceptible to attack by electrophilic chemotherapeutic agents (PubChem: Guanine). Drugs such as platinum-based compounds and alkylating agents bind covalently to these sites, creating bulky adducts or cross-links between DNA strands. These structural modifications disrupt the integrity of the DNA template, preventing successful replication and transcription, which ultimately induces cell cycle arrest and programmed cell death (apoptosis) (PubMed: PMID 24970696). While these interactions are a cornerstone of traditional chemotherapy, the lack of specificity for cancerous versus healthy DNA leads to significant clinical side effects, including bone marrow suppression and the risk of developing secondary cancers due to the mutagenic nature of the DNA damage.

Other names

Guanine2-amino-1,9-dihydro-6H-purin-6-oneDeoxyguanosinedGGuanine nucleotide

Chemotherapeutic agents target DNA guanine bases by forming covalent bonds at nucleophilic sites, most commonly the N7 position of the imidazole ring or the O6 position of the purine. This results in the formation of DNA adducts and cross-links (intrastrand or interstrand) that distort the DNA double helix, physically obstructing DNA replication and RNA transcription (StatPearls: Alkylating Agents; NIH: Cisplatin). These lesions activate DNA damage response pathways, such as the p53 pathway, leading to cell cycle arrest and apoptosis in rapidly dividing cells.